Thymidine phosphorylase gene sequence variances having utility in determining the treatment of disease
US6759200B1 · kind B1 · utility
26Cited by
4References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 24, 2001 |
| Grant date | Jul 6, 2004 |
| Priority date | — |
| Expiry date | Oct 30, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/172
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure describes the use of genetic variance information for folate transport or metabolism genes or pyrimidine transport or metabolism genes in the selection of effective methods of treatment of a disease or condition. The variance information is indicative of the expected response of a patient to a method of treatment. Methods of determining relevant variance information and additional methods of using such variance information are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.